Long-term safety and efficacy of daclizumab beta in relapsing–remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study

被引：0
作者：
Ralf Gold
Ernst-Wilhelm Radue
Gavin Giovannoni
Krzysztof Selmaj
Eva Kubala Havrdova
Xavier Montalban
Dusan Stefoski
Till Sprenger
Randy R. Robinson
Sami Fam
Jonathan Smith
Spyros Chalkias
Giorgio Giannattasio
Gabriel Lima
Wanda Castro-Borrero
机构：
[1] St. Josef-Hospital/Ruhr-University Bochum,Medical Image Analysis Center
[2] University Hospital Basel,Barts and The London School of Medicine and Dentistry
[3] Queen Mary University of London,Department of Neurology
[4] University of Warmia and Mazury,Department of Neurology, First Faculty of Medicine
[5] Charles University,undefined
[6] Hospital Vall d’Hebron University,undefined
[7] Rush University Medical Center,undefined
[8] DKD Helios Klinik Wiesbaden,undefined
[9] AbbVie Inc.,undefined
[10] Biogen,undefined
[11] Biogen,undefined
来源：
Journal of Neurology | 2020年 / 267卷
关键词：
Daclizumab beta; Relapsing–remitting multiple sclerosis; SELECTED; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2851 / 2864
页数：13
相关论文
共 50 条
  • [21] Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study
    Barish, Charles F.
    Griffin, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (04) : 751 - 755
  • [22] Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
    Baraliakos, Xenofon
    Deodhar, Atul
    Dougados, Maxime
    Gensler, Lianne S.
    Molto, Anna
    Ramiro, Sofia
    Kivitz, Alan J.
    Poddubnyy, Denis
    Oortgiesen, Marga
    Vaux, Thomas
    Fleurinck, Carmen
    Shepherd-Smith, Julie
    de la Loge, Christine
    de Peyrecave, Natasha
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (12) : 1943 - 1958
  • [23] Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
    Singer, Barry A.
    Arnold, Douglas L.
    Drulovic, Jelena
    Freedman, Mark S.
    Gold, Ralf
    Gudesblatt, Mark
    Jasinska, Elzbieta
    Laganke, Christopher C.
    Naismith, Robert T.
    Negroski, Donald
    Oh, Jiwon
    Perez, Miguel Angel Hernandez
    Selmaj, Krzysztof
    Bergh, Florian Then
    Wundes, Annette
    Ziemssen, Tjalf
    Castro-Borrero, Wanda
    Chen, Hailu
    Levin, Seth
    Scaramozza, Matthew
    Shankar, Sai L.
    Wang, Ting
    Wray, Sibyl
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (14) : 1795 - 1807
  • [24] Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials
    Atkinson, Sarah
    Thurman, Louise
    Ramaker, Sara
    Buckley, Gina
    Jones, Sara Ramaker
    England, Richard
    Wajsbro, Dalia
    CNS SPECTRUMS, 2019, 24 (05) : 496 - 506
  • [25] An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain
    Onouchi, Kenji
    Koga, Hiroaki
    Yokoyama, Kazumasa
    Yoshiyama, Tamotsu
    JOURNAL OF PAIN RESEARCH, 2014, 7 : 439 - 447
  • [26] Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients
    Slevin, John T.
    Fernandez, Hubert H.
    Zadikoff, Cindy
    Hall, Coleen
    Eaton, Susan
    Dubow, Jordan
    Chatamra, Krai
    Benesh, Janet
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (01) : 165 - 174
  • [27] Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)
    Neve, Anuja
    Das, Bibha
    Wojtowicz, Jakub
    Huang, Zhiyue
    Bullain, Szofia
    Watkin, Michelle
    Lott, Dominik
    Bittner, Tobias
    Delmar, Paul
    Klein, Gregory
    Hofmann, Carsten
    Kerchner, Geoffrey A.
    Smith, Janice
    Baudler, Monika
    Fontoura, Paulo
    Doody, Rachelle S.
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 (01) : 353 - 367
  • [28] Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study
    Naismith, Robert T.
    Wolinsky, Jerry S.
    Wundes, Annette
    LaGanke, Christopher
    Arnold, Douglas L.
    Obradovic, Dragana
    Freedman, Mark S.
    Gudesblatt, Mark
    Ziemssen, Tjalf
    Kandinov, Boris
    Bidollari, Ilda
    Lopez-Bresnahan, Maria
    Nangia, Narinder
    Rezendes, David
    Yang, Lili
    Chen, Hailu
    Liu, Shifang
    Hanna, Jerome
    Miller, Catherine
    Leigh-Pemberton, Richard
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (13) : 1729 - 1739
  • [29] Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
    McElvaney, Noel G.
    Burdon, Jonathan
    Holmes, Mark
    Glanville, Allan
    Wark, Peter A. B.
    Thompson, Philip J.
    Hernandez, Paul
    Chlumsky, Jan
    Teschler, Helmut
    Ficker, Joachim H.
    Seersholm, Niels
    Altraja, Alan
    Makitaro, Riitta
    Chorostowska-Wynimko, Joanna
    Sanak, Marek
    Stoicescu, Paul I.
    Piitulainen, Eeva
    Vit, Oliver
    Wencker, Marion
    Tortorici, Michael A.
    Fries, Michael
    Edelman, Jonathan M.
    Chapman, Kenneth R.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01) : 51 - 60
  • [30] Long-term efficacy and safety of oral almotriptan: Interim analysis of a 1-year open study
    Cabarrocas, X
    Esbri, R
    Peris, F
    Ferrer, P
    HEADACHE, 2001, 41 (01): : 57 - 62
12345